Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Arthritis Research & Therapy

Figure 1

From: Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease

Figure 1

Serum concentrations of IL-15 in patients with systemic sclerosis increase compared with healthy control individuals. Striped circles, patients on cortisone treatment; filled circles, two patients with renal crises; horizontal bars, median (25th and 75th percentiles) in each group; dashed line, cut-off value for increased serum levels of IL-15 (75th percentile of all systemic sclerosis (SSc)); fine dotted line, detection level. dcSSc, diffuse cutaneous systemic sclerosis; lcSSc, limited cutaneous systemic sclerosis; n.s., not significant.

Back to article page